JP Patent

JP6334519B2 — 天然の併用ホルモン補充療法剤及び治療

Assigned to TherapeuticsMD Inc · Expires 2018-05-30 · 8y expired

What this patent protects

Patent listed against Estrace.

Drugs covered by this patent

Patent Metadata

Patent number
JP6334519B2
Jurisdiction
JP
Classification
—
Expires
2018-05-30
Drug substance claim
No
Drug product claim
No
Assignee
TherapeuticsMD Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.